Thymoma-associated pancytopenia: immunosuppressive therapy is the cornerstone for durable hematological remission

Ashish V. Chintakuntlawar, Syed A. Rizvi, Stephen D. Cassivi, Animesh Pardanani

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Pancytopenia is a very rare complication of thymoma and has been sporadically reported in only a few cases. We report a case of a 68-year-old woman who presented with pancytopenia associated with thymoma. After failing high-dose corticosteroids, she responded to cyclosporine treatment and underwent successful thymectomy. We also reviewed all other similar cases published in the English language literature. Surgical resection by itself was generally ineffective for treatment of pancytopenia, and immunosuppressive therapy was required for bone marrow recovery. Resolution of pancytopenia was most frequently associated with cyclosporine-based therapy with a response rate (RR) of 66.6 %. In conclusion, pancytopenia associated with thymoma requires medical treatment, and the evidence presented here suggests that a cyclosporine-based regimen should be considered for initial therapy.

Original languageEnglish (US)
Pages (from-to)453-458
Number of pages6
JournalAnnals of hematology
Volume94
Issue number3
DOIs
StatePublished - Jan 1 2015

Keywords

  • Aplastic anemia
  • Pancytopenia
  • Thymoma

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Thymoma-associated pancytopenia: immunosuppressive therapy is the cornerstone for durable hematological remission'. Together they form a unique fingerprint.

  • Cite this